Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 19 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2024 Filed Jul 2, 2024 22:12 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-022025 · rdgdoc.xml · derivative · entry 3 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,271 Underlying: Common Stock · 8,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:12 UTC |
Cittadine AndrewChief Operating Officer
|
Tax withholdingCommon Stock | 2,019 | $0.73 | $1,475.89 |
DisclosureSEC source: 0001437749-24-022025 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,065 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:12 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionCommon Stock | 8,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022025 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:08 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-022024 · rdgdoc.xml · derivative · entry 3 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,412 Underlying: Common Stock · 9,957 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:08 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Tax withholdingCommon Stock | 2,998 | $0.73 | $2,191.54 |
DisclosureSEC source: 0001437749-24-022024 · rdgdoc.xml · nonDerivative · entry 2 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,429 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:08 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionCommon Stock | 9,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022024 · rdgdoc.xml · nonDerivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:07 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 24,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-022023 · rdgdoc.xml · derivative · entry 5 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,335 Underlying: Common Stock · 24,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F5 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F6 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F7 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F6 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F7 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:07 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 8,684 | $0.73 | $6,348.00 |
DisclosureSEC source: 0001437749-24-022023 · rdgdoc.xml · nonDerivative · entry 2 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,922.8 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 22:07 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 24,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-022023 · rdgdoc.xml · nonDerivative · entry 1 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,606.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:16 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 20,508 | $0.74 | $15,253.85 |
DisclosureSEC source: 0001437749-24-021000 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,132 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.73691 to $0.75860, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| June 18, 2024 Filed Jun 21, 2024 21:16 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.86 | $10,320.00 |
DisclosureSEC source: 0001437749-24-021000 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,624 Read SEC document |
| June 17, 2024 Filed Jun 17, 2024 22:08 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.90 | $10,798.80 |
DisclosureSEC source: 0001437749-24-020547 · rdgdoc.xml · nonDerivative · entry 3 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,624 Read SEC document |
| June 14, 2024 Filed Jun 17, 2024 22:08 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.93 | $11,175.60 |
DisclosureSEC source: 0001437749-24-020547 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,624 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9100 to $0.93994, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| June 13, 2024 Filed Jun 17, 2024 22:08 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.91 | $10,920.00 |
DisclosureSEC source: 0001437749-24-020547 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,624 Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 22:12 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.78 | $9,360.00 |
DisclosureSEC source: 0001437749-24-019370 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,624 Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 22:12 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.76 | $9,120.00 |
DisclosureSEC source: 0001437749-24-019370 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,624 Read SEC document |
| May 31, 2024 Filed May 31, 2024 20:56 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.64 | $7,731.60 |
DisclosureSEC source: 0001437749-24-018931 · rdgdoc.xml · nonDerivative · entry 3 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,624 F3 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.61 to $0.6502, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| May 30, 2024 Filed May 31, 2024 20:56 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.64 | $7,676.40 |
DisclosureSEC source: 0001437749-24-018931 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,624 F2 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.629 to $0.64, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| May 29, 2024 Filed May 31, 2024 20:56 UTC |
Cittadine AndrewChief Operating Officer
|
PurchaseCommon Stock | 12,000 | $0.64 | $7,642.80 |
DisclosureSEC source: 0001437749-24-018931 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,624 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.629 to $0.637, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:10 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
OtherStock Options · Derivative | 84,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-018775 · rdgdoc.xml · derivative · entry 4 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,000 shares Expires 2026-04-03 F4 · derivative.exercise_date: Reflects options to purchase up to 84,000 shares of common stock granted to Dr. Robinson on April 4, 2016 for his services as a director and officer of Monopar Therapeutics. The options vested 50% upon grant date, 25% upon the 6-month anniversary of grant date, and 25% upon the 1-year anniversary of grant date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 22:10 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
OtherCommon Stock | 84,000 | $0.00 | $84.00 |
DisclosureSEC source: 0001437749-24-018775 · rdgdoc.xml · nonDerivative · entry 1 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,130.8 F1 · shares: This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. Read SEC document |
| May 22, 2024 Filed May 24, 2024 20:59 UTC |
Cittadine AndrewChief Operating Officer
|
GrantStock Options · Derivative | 25,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001437749-24-018353 · rdgdoc.xml · derivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-05-22 F1 · derivative.exercise_date: Options vest 6/48ths on November 21, 2024 and 1/48th per month thereafter. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:35 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010723 · rdgdoc.xml · derivative · entry 3 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,223 Underlying: Common Stock · 8,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:35 UTC |
Cittadine AndrewChief Operating Officer
|
Tax withholdingCommon Stock | 3,098 | $0.68 | $2,109.74 |
DisclosureSEC source: 0001437749-24-010723 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,624 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:35 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionCommon Stock | 8,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-010723 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:33 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,956 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010722 · rdgdoc.xml · derivative · entry 3 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,369 Underlying: Common Stock · 9,956 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:33 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Tax withholdingCommon Stock | 4,082 | $0.68 | $2,779.84 |
DisclosureSEC source: 0001437749-24-010722 · rdgdoc.xml · nonDerivative · entry 2 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,470 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:33 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionCommon Stock | 9,956 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-010722 · rdgdoc.xml · nonDerivative · entry 1 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:33 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 24,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010721 · rdgdoc.xml · derivative · entry 5 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,811 Underlying: Common Stock · 24,474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F5 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F6 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F7 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 63,060 restricted stock units, vesting 6/48ths (7,883 shares) on June 30, 2021, and 3/48ths (3,941 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F6 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 159,522 restricted stock units, vesting 6/48ths (19,940 shares) on June 30, 2022, and 3/48ths (9,970 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F7 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 169,012 restricted stock units, vesting 6/48ths (21,127 shares) on June 30, 2023, and 3/48ths (10,563 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:33 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 7,172 | $0.68 | $4,884.13 |
DisclosureSEC source: 0001437749-24-010721 · rdgdoc.xml · nonDerivative · entry 2 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,130.8 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 3, 2024 00:33 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 24,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-010721 · rdgdoc.xml · nonDerivative · entry 1 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,302.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| March 31, 2024 Filed Apr 3, 2025 01:08 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-010810 · rdgdoc.xml · derivative · entry 3 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,864 Underlying: Common Stock · 1,791 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 13,000 restricted stock units, vesting 6/48ths (1,625 shares) on June 30, 2022, and 3/48ths (813 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 15,647 restricted stock units, vesting 6/48ths (1,956 shares) on June 30, 2023, and 3/48ths (978 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:33 UTC |
RIOUX PATRICEActing Chief Medical Officer
|
GrantStock Options · Derivative | 10,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001437749-24-000479 · rdgdoc.xml · derivative · entry 1 RIOUX PATRICE · CIK 0001241033 · Acting Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-12-31 F1 · derivative.exercise_date: Stock Options vesting commenced on January 1, 2024 as follows: 833 on January 31, 2024 and each subsequent month-end thereafter. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:34 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,231 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000480 · rdgdoc.xml · derivative · entry 6 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,325 Underlying: Common Stock · 1,231 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F6 · derivative.exercise_date: On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F6 · derivative.expiration_date: On January 31, 2020 the reporting person was granted 4,923 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:34 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Tax withholdingCommon Stock | 505 | $0.34 | $171.80 |
DisclosureSEC source: 0001437749-24-000480 · rdgdoc.xml · nonDerivative · entry 4 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,596 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:34 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionCommon Stock | 1,231 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000480 · rdgdoc.xml · nonDerivative · entry 3 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:36 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000482 · rdgdoc.xml · derivative · entry 10 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,285 Underlying: Common Stock · 6,724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F8 · derivative.exercise_date: On January 31, 2020 the reporting person was granted 26,895 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F8 · derivative.expiration_date: On January 31, 2020 the reporting person was granted 26,895 restricted stock units, vesting in four equal annual installments with vesting dates on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:36 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 2,327 | $0.34 | $791.65 |
DisclosureSEC source: 0001437749-24-000482 · rdgdoc.xml · nonDerivative · entry 6 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,828.8 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:36 UTC |
Robinson ChandlerDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 6,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000482 · rdgdoc.xml · nonDerivative · entry 5 Robinson Chandler · CIK 0001727334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,155.8 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC |
Brown Michael JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000487 · rdgdoc.xml · derivative · entry 4 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:40 UTC |
Brown Michael JDirector
|
Exercise / conversionCommon Stock | 2,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000487 · rdgdoc.xml · nonDerivative · entry 1 Brown Michael J · CIK 0001035909 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:39 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000486 · rdgdoc.xml · derivative · entry 3 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,175 Underlying: Common Stock · 8,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F2 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F2 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 65,000 restricted stock units, vesting 6/48ths (8,125 shares) on June 30, 2022, and 3/48ths (4,063 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:39 UTC |
Cittadine AndrewChief Operating Officer
|
Tax withholdingCommon Stock | 3,098 | $0.34 | $1,053.94 |
DisclosureSEC source: 0001437749-24-000486 · rdgdoc.xml · nonDerivative · entry 2 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,770 F3 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:39 UTC |
Cittadine AndrewChief Operating Officer
|
Exercise / conversionCommon Stock | 8,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000486 · rdgdoc.xml · nonDerivative · entry 1 Cittadine Andrew · CIK 0001863624 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:37 UTC |
STARR CHRISTOPHER MDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000483 · rdgdoc.xml · derivative · entry 3 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 19:37 UTC |
STARR CHRISTOPHER MDirector
|
Exercise / conversionCommon Stock | 2,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000483 · rdgdoc.xml · nonDerivative · entry 1 STARR CHRISTOPHER M · CIK 0001235470 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:38 UTC |
KLAUSNER ARTHUR JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000484 · rdgdoc.xml · derivative · entry 3 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,533 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:38 UTC |
KLAUSNER ARTHUR JDirector
|
Exercise / conversionCommon Stock | 2,533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-000484 · rdgdoc.xml · nonDerivative · entry 1 KLAUSNER ARTHUR J · CIK 0001207790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares acquired on vesting and settlement of restricted stock units. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:34 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-000480 · rdgdoc.xml · derivative · entry 5 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,556 Underlying: Common Stock · 9,957 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents shares acquired on vesting and settlement of restricted stock units. F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.exercise_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.exercise_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F4 · derivative.expiration_date: On February 2, 2022, the reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. F5 · derivative.expiration_date: On February 1, 2023, the reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. Read SEC document |
| December 31, 2023 Filed Jan 4, 2024 00:34 UTC |
Tsuchimoto Kim RDirector · Chief Financial Officer
|
Tax withholdingCommon Stock | 4,073 | $0.34 | $1,385.63 |
DisclosureSEC source: 0001437749-24-000480 · rdgdoc.xml · nonDerivative · entry 2 Tsuchimoto Kim R · CIK 0001333516 · Director · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,870 F2 · shares: Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.